The prevention of heart failure--a new agenda

Clinical Trial

J N Cohn. N Engl J Med. 1992.

. 1992 Sep 3;327(10):725-7.

doi: 10.1056/NEJM199209033271010.

Erratum in

No abstract available

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, et al. Pfeffer MA, et al. N Engl J Med. 1992 Sep 3;327(10):669-77. doi: 10.1056/NEJM199209033271001. N Engl J Med. 1992. PMID: 1386652 Clinical Trial.
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.
SOLVD Investigators; Yusuf S, Pitt B, Davis CE, Hood WB Jr, Cohn JN. SOLVD Investigators, et al. N Engl J Med. 1992 Sep 3;327(10):685-91. doi: 10.1056/NEJM199209033271003. N Engl J Med. 1992. PMID: 1463530 Clinical Trial.
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II).
Swedberg K, Held P, Kjekshus J, Rasmussen K, Rydén L, Wedel H. Swedberg K, et al. N Engl J Med. 1992 Sep 3;327(10):678-84. doi: 10.1056/NEJM199209033271002. N Engl J Med. 1992. PMID: 1495520 Clinical Trial.